Clinical Trials Logo
  1. Home
  2. Liver Cirrhosis
  3. NCT02468479
  4. Details
NCT02468479 Clinical Trial

Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis

Liver Cirrhosis Clinical Trial

Official title:
Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02468479
Other study ID # CAWV-LC
Secondary ID
Status Completed
Phase N/A
First received June 4, 2015
Last updated April 18, 2017
Start date June 2015
Est. completion date December 2016

Study information
Verified date April 2017
Source General Hospital of Shenyang Military Region
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Chest/abdominal wall varices and spider nevi are two common presenting signs of liver cirrhosis. Their prognostic values remain unclear.

Recruitment information / eligibility
Status Completed
Enrollment 200
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

1. Liver cirrhosis.

2. Consecutive admission.

3. Permitted to physical examinations.

4. Informed consents.

Exclusion Criteria:

1. Non-cirrhotic portal hypertension.

2. Malignancy.

3. Uncontrolled infection.

4. Severe chronic diseases.

5. Poor patient compliance.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• No relevant intervention.
No relevant intervention.

Locations
Country Name City State
China Department of Gastroenterology, General Hospital of Shenyang Military Area Shenyang Liaoning

Sponsors (1)
Lead Sponsor Collaborator
General Hospital of Shenyang Military Region

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence and type of chest/abdominal wall varices and spider nevi Baseline data 1.5 years
Primary Association between etiology of liver cirrhosis and type of chest/abdominal wall varices and spider nevi Baseline data 1.5 years
Primary Association between degree of liver function and type of chest/abdominal wall varices and spider nevi Baseline data 1.5 years
Primary Effect of chest/abdominal wall varices and spider nevi on survival Follow-up data 2.5 years or more
See also
  Status Clinical Trial Phase
Recruiting NCT04533932 - Endosonographic Shear Wave Elastography for Liver Stiffness
Not yet recruiting NCT06031740 - A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids N/A
Not yet recruiting NCT06026267 - Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis N/A
Not yet recruiting NCT06076330 - Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension N/A
Enrolling by invitation NCT05055713 - A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism N/A
Recruiting NCT04578301 - Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Not yet recruiting NCT05515861 - Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices N/A
Not yet recruiting NCT05120557 - Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH N/A
Not yet recruiting NCT02710227 - Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis N/A
Not yet recruiting NCT03623360 - Functional MRI to Determine Severity of Cirrhosis
Completed NCT02917408 - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Active, not recruiting NCT02551250 - Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
Recruiting NCT02239991 - Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant N/A
Enrolling by invitation NCT02256514 - Open Label Trial of Immunotherapy for Advanced Liver Cancer Phase 2
Terminated NCT02311985 - Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial N/A
Terminated NCT01937130 - Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF Phase 2
Recruiting NCT01724697 - Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis Phase 1/Phase 2
Recruiting NCT01618890 - Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding Phase 3
Recruiting NCT01728727 - Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis Phase 1/Phase 2
Recruiting NCT01728688 - Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis Phase 1/Phase 2